Clearstead Advisors’s IDEAYA Biosciences IDYA Stock Holding History

Clearstead Advisors’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-528	Closed	-$8.65K	–	2804
2025 Q1	$8.65K	Hold	528	–	–	﹤0.01%	1641
2024 Q4	$13.6K	Hold	528	–	–	﹤0.01%	1501
2024 Q3	$16.7K	Buy	528 +111	+27%	+$4.21K	﹤0.01%	1475
2024 Q2	$14.6K	Buy	+417	New	+$16.5K	﹤0.01%	1454
2023 Q1	–	Sell	-1,251	Closed	-$22.7K	–	1397
2022 Q4	$22.7K	Hold	1,251	–	–	﹤0.01%	777
2022 Q3	$19K	Hold	1,251	–	–	﹤0.01%	780
2022 Q2	$17K	Hold	1,251	–	–	﹤0.01%	834
2022 Q1	$14K	Hold	1,251	–	–	﹤0.01%	928
2021 Q4	$30K	Sell	1,251 -625	-33%	-$14.5K	﹤0.01%	734
2021 Q3	$48K	Hold	1,876	–	–	﹤0.01%	617
2021 Q2	$39K	Hold	1,876	–	–	﹤0.01%	596
2021 Q1	$44K	Buy	+1,876	New	+$36.2K	﹤0.01%	561

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Clearstead Advisors's IDYA Position: Q2 2025 in Review

Clearstead Advisors sold out of IDEAYA Biosciences (IDYA) in Q2 2025, closing a stake of 528 shares — an estimated $8.65K sold.

Clearstead Advisors first reported a position in IDYA in Q1 2021 and held it in 12 quarters. The position peaked at $48K in Q3 2021. 204 funds tracked by Wall St. Rank hold IDYA as of Q2 2025.

Clearstead Advisors reported no remaining IDEAYA Biosciences position as of Q2 2025 after selling out during the quarter.
Clearstead Advisors sold 528 IDEAYA Biosciences shares in Q2 2025, an estimated $8.65K.
Clearstead Advisors first reported a position in IDEAYA Biosciences in Q1 2021 and held it in 12 quarters.
Clearstead Advisors's IDEAYA Biosciences position peaked at $48K in Q3 2021.
204 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2025.

Based on Clearstead Advisors's 13F filing for Q2 2025, filed 8 Aug 2025.